Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 14 |
NetGPI | no | yes: 0, no: 14 |
Related structures:
AlphaFold database: Q4QHP5
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0016579 | protein deubiquitination | 6 | 3 |
GO:0019538 | protein metabolic process | 3 | 3 |
GO:0036211 | protein modification process | 4 | 3 |
GO:0043170 | macromolecule metabolic process | 3 | 3 |
GO:0043412 | macromolecule modification | 4 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0070646 | protein modification by small protein removal | 5 | 3 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 15 |
GO:0008233 | peptidase activity | 3 | 15 |
GO:0016787 | hydrolase activity | 2 | 15 |
GO:0019783 | ubiquitin-like protein peptidase activity | 4 | 3 |
GO:0101005 | deubiquitinase activity | 5 | 3 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 15 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 209 | 213 | PF00656 | 0.522 |
CLV_NRD_NRD_1 | 110 | 112 | PF00675 | 0.203 |
CLV_PCSK_SKI1_1 | 157 | 161 | PF00082 | 0.565 |
DOC_CYCLIN_yCln2_LP_2 | 146 | 149 | PF00134 | 0.527 |
DOC_CYCLIN_yCln2_LP_2 | 184 | 187 | PF00134 | 0.419 |
DOC_MAPK_MEF2A_6 | 32 | 41 | PF00069 | 0.292 |
DOC_PP2B_LxvP_1 | 146 | 149 | PF13499 | 0.528 |
DOC_PP2B_LxvP_1 | 184 | 187 | PF13499 | 0.400 |
DOC_PP4_FxxP_1 | 215 | 218 | PF00568 | 0.581 |
DOC_USP7_MATH_1 | 15 | 19 | PF00917 | 0.596 |
DOC_USP7_MATH_1 | 159 | 163 | PF00917 | 0.643 |
DOC_USP7_MATH_1 | 187 | 191 | PF00917 | 0.511 |
DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.492 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.730 |
DOC_WW_Pin1_4 | 86 | 91 | PF00397 | 0.487 |
LIG_EH_1 | 212 | 216 | PF12763 | 0.580 |
LIG_eIF4E_1 | 179 | 185 | PF01652 | 0.428 |
LIG_EVH1_2 | 90 | 94 | PF00568 | 0.465 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.461 |
LIG_LIR_Apic_2 | 212 | 218 | PF02991 | 0.547 |
LIG_LIR_Gen_1 | 126 | 136 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 126 | 131 | PF02991 | 0.470 |
LIG_MYND_1 | 182 | 186 | PF01753 | 0.412 |
LIG_Pex14_2 | 138 | 142 | PF04695 | 0.471 |
LIG_Pex14_2 | 94 | 98 | PF04695 | 0.545 |
LIG_SH2_CRK | 128 | 132 | PF00017 | 0.485 |
LIG_SH2_CRK | 179 | 183 | PF00017 | 0.423 |
LIG_SH2_NCK_1 | 27 | 31 | PF00017 | 0.420 |
LIG_SH2_SRC | 27 | 30 | PF00017 | 0.428 |
LIG_SH2_SRC | 70 | 73 | PF00017 | 0.564 |
LIG_SH2_STAP1 | 195 | 199 | PF00017 | 0.617 |
LIG_SH2_STAP1 | 27 | 31 | PF00017 | 0.589 |
LIG_SH2_STAP1 | 66 | 70 | PF00017 | 0.551 |
LIG_SH2_STAT5 | 199 | 202 | PF00017 | 0.553 |
LIG_SH3_3 | 180 | 186 | PF00018 | 0.411 |
MOD_CK1_1 | 190 | 196 | PF00069 | 0.330 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.677 |
MOD_CK2_1 | 103 | 109 | PF00069 | 0.478 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.366 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.644 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.596 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.557 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.568 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.649 |
MOD_GlcNHglycan | 76 | 81 | PF01048 | 0.350 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.600 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.501 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.484 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.513 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.655 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.533 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.700 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.639 |
MOD_PIKK_1 | 100 | 106 | PF00454 | 0.521 |
MOD_PKA_2 | 190 | 196 | PF00069 | 0.595 |
MOD_Plk_4 | 195 | 201 | PF00069 | 0.567 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.515 |
MOD_ProDKin_1 | 86 | 92 | PF00069 | 0.487 |
TRG_DiLeu_BaEn_1 | 109 | 114 | PF01217 | 0.531 |
TRG_ENDOCYTIC_2 | 128 | 131 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.506 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HVE7 | Leptomonas seymouri | 50% | 89% |
A0A0N1PCI8 | Leptomonas seymouri | 65% | 97% |
A0A1X0NHT4 | Trypanosomatidae | 41% | 75% |
A0A3Q8IAW2 | Leishmania donovani | 92% | 100% |
A0A3S7WQX3 | Leishmania donovani | 55% | 86% |
A0A422NZN2 | Trypanosoma rangeli | 42% | 89% |
A4H5V8 | Leishmania braziliensis | 75% | 98% |
A4HU52 | Leishmania infantum | 93% | 100% |
A4HU53 | Leishmania infantum | 54% | 86% |
D0A9N3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 92% |
E9AMY1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
E9AMY2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 57% | 86% |
Q4QHP4 | Leishmania major | 60% | 100% |